Coya Therapeutics, Inc./$COYA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
- Ticker
- $COYA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 8
- Headquarters
- Houston, United States
- Website
- www.coyatherapeutics.com
COYA Metrics
BasicAdvanced
$75M
-
-$1.40
-
-
Price and volume
Market cap
$75M
52-week high
$6.62
52-week low
$2.72
Average daily volume
165K
Financial strength
Current ratio
7.242
Quick ratio
6.636
Profitability
EBITDA (TTM)
-29.843
Gross margin (TTM)
-256.89%
Net profit margin (TTM)
-643.45%
Operating margin (TTM)
-636.77%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
-52.30%
Return on equity (TTM)
-99.16%
Valuation
Price to revenue (TTM)
14.772
Price to book
2.24
Price to tangible book (TTM)
2.24
Price to free cash flow (TTM)
-2.962
Free cash flow yield (TTM)
-33.76%
Free cash flow per share (TTM)
-1.084
Growth
Revenue change (TTM)
17.59%
Earnings per share change (TTM)
25.92%
3-year earnings per share growth (CAGR)
-3.06%
What the Analysts think about COYA
Analyst ratings (Buy, Hold, Sell) for Coya Therapeutics, Inc. stock.
Analyst projections of the future price of Coya Therapeutics, Inc. stock.
COYA Financial Performance
Revenues and expenses
COYA Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.